Team:SJTU-BioX-Shanghai/Results

From 2014.igem.org

(Difference between revisions)
Line 19: Line 19:
<h3>Reformed Plasmid Result</h3>
<h3>Reformed Plasmid Result</h3>
<p>We designed four reformed plasmids, pBluescript II KS(+) ScaI deletion, pBluescript II KS(+) EcoRV deletion, pBluescript II KS(+)_3_copy, pBluescript II KS(+)_5_copy.
<p>We designed four reformed plasmids, pBluescript II KS(+) ScaI deletion, pBluescript II KS(+) EcoRV deletion, pBluescript II KS(+)_3_copy, pBluescript II KS(+)_5_copy.
-
And we test their co-transformation ability and get the result picture. All of these plasmid has Amp antibiotic resistance. </p>
+
And we tested their co-transformation ability and got the result picture. All of these plasmids have Amp antibiotic resistance. </p>
<p>
<p>
-
We co-transformed pRSFDuet-1 and two plasmids, pBluescript II KS(+) ScaI deletion & pBluescript II KS(+) EcoRV deletion, respectively. So the plate has two antibiotic resistance, Kan and Amp. We culture two different strains on the plate and get the result picture.</p>
+
We co-transformed pRSFDuet-1 and two plasmids, pBluescript II KS(+) ScaI deletion & pBluescript II KS(+) EcoRV deletion, respectively. So the plate has two antibiotic resistance, Kan and Amp. We cultured two different strains on the plate and got the result picture.</p>
<center><img src="https://static.igem.org/mediawiki/2014/5/5f/123123123.jpg" width=600px></img></center>
<center><img src="https://static.igem.org/mediawiki/2014/5/5f/123123123.jpg" width=600px></img></center>
Line 27: Line 27:
<center><small><strong>Figure 2.1.1 Two plates of Co-transfected bacteria (pBluescript II KS(+) ScaI deletion & pBluescript II KS(+) EcoRV deletion)</small></strong></center>
<center><small><strong>Figure 2.1.1 Two plates of Co-transfected bacteria (pBluescript II KS(+) ScaI deletion & pBluescript II KS(+) EcoRV deletion)</small></strong></center>
-
<p>Moreover, we verify our pBluescript II KS(+)_3_copy, pBluescript II KS(+)_5_copy part through lacl & blue-white spot screening.</p>
+
<p>Moreover, we verified our pBluescript II KS(+)_3_copy, pBluescript II KS(+)_5_copy part through lacl & blue-white spot screening.</p>
<center><img src="https://static.igem.org/mediawiki/2014/c/c6/212121.jpg" width=600px></img></center>
<center><img src="https://static.igem.org/mediawiki/2014/c/c6/212121.jpg" width=600px></img></center>
Line 33: Line 33:
<center><small><strong>Figure 2.1.2 Two plates of lacl & blue-white spot screening</strong></small></center>
<center><small><strong>Figure 2.1.2 Two plates of lacl & blue-white spot screening</strong></small></center>
-
<p>So we experimentally validate that our reformed plasmids perform as expected. </p>
+
<p>So we have experimentally validated that our reformed plasmids perform as expected. </p>
<h3>TAL USB function identification</h3>
<h3>TAL USB function identification</h3>
-
<p>The membrane anchor system (ssDsbA-Lgt) comes from iGEM12_SJTU-BioX-Shanghai BBa_K771000
+
<p>The membrane anchor system (ssDsbA-Lgt) comes from iGEM12_SJTU-BioX-Shanghai BBa_K771000.
In order to connect TAL protein designed by 2012 Freiburg iGEM team, the TAL USB also consists of T1 sequence, T14 sequence and two sites for type II restriction enzyme BsmBI.</p>
In order to connect TAL protein designed by 2012 Freiburg iGEM team, the TAL USB also consists of T1 sequence, T14 sequence and two sites for type II restriction enzyme BsmBI.</p>
<center><img src="https://static.igem.org/mediawiki/2014/9/9b/Part%EF%BC%9ABBa_K1453000.png" width=600px></img></center>
<center><img src="https://static.igem.org/mediawiki/2014/9/9b/Part%EF%BC%9ABBa_K1453000.png" width=600px></img></center>
<center><small><strong>Figure 2.1.3 The structure of TAL USB</strong></small></center>
<center><small><strong>Figure 2.1.3 The structure of TAL USB</strong></small></center>
<p>
<p>
-
When digested with BsmBI, this part can produce two sticky-ends that can bind TAL-Protein (BBa_K747000 to BBa_K747095)
+
When digested with BsmBI, this part produces two sticky-ends that can bind TAL-Protein (BBa_K747000 to BBa_K747095)
-
After doing ligation with T4 Ligase, we experimentally validated this part's function.</p>
+
After doing ligation with T4 ligase, we experimentally validated this part's function.</p>
<p>
<p>
Sequencing result is followed:</p>
Sequencing result is followed:</p>
Line 77: Line 77:
</center></pre>
</center></pre>
-
<p>Furthermore, we find some mismatch cases in our sequencing result. Here are a typical mismatch result.</p>
+
<p>Furthermore, we found some mismatch cases in our sequencing result. Here are a typical mismatch result.</p>
<p>There is the partial sequencing result.</p>
<p>There is the partial sequencing result.</p>
<center><img src="https://static.igem.org/mediawiki/2014/f/f5/%E5%B1%8F%E5%B9%95%E5%BF%AB%E7%85%A7_2014-10-18_%E4%B8%8A%E5%8D%881.26.07.png" width=700px></img><center>
<center><img src="https://static.igem.org/mediawiki/2014/f/f5/%E5%B1%8F%E5%B9%95%E5%BF%AB%E7%85%A7_2014-10-18_%E4%B8%8A%E5%8D%881.26.07.png" width=700px></img><center>
Line 83: Line 83:
<center><strong><small>Figure 2.1.4 Partial sequencing result of mismatch</strong></small></center>
<center><strong><small>Figure 2.1.4 Partial sequencing result of mismatch</strong></small></center>
-
<p>We try to understand why we get this wrong sequence. We Check our part and 2012 Freiburg's project. And we find that the the mismatch sticky end appearing in original sequence is <b>GCTC</b> and <b>ACTC</b>. What a similar sticky ends! Here are the two components in the mismatch sequence. </p>
+
<p>We tried to understand why we got this wrong sequence. We checked our part and 2012 Freiburg's project. And we found that the the mismatch sticky ends appearing in original sequence are <b>GCTC</b> and <b>ACTC</b>. What similar sticky ends! Here are the two components in the mismatch sequence. </p>
<center><img src="https://static.igem.org/mediawiki/2014/d/dd/%E5%B1%8F%E5%B9%95%E5%BF%AB%E7%85%A7_2014-10-18_%E4%B8%8A%E5%8D%882.40.42.png" width=800px></img></center>
<center><img src="https://static.igem.org/mediawiki/2014/d/dd/%E5%B1%8F%E5%B9%95%E5%BF%AB%E7%85%A7_2014-10-18_%E4%B8%8A%E5%8D%882.40.42.png" width=800px></img></center>
-
<center><strong><small>Figure 2.1.5 The process of mismatch generating</small></strong></center>
+
<center><strong><small>Figure 2.1.5 The process of generating mismatch</small></strong></center>
-
<p>So the sequencing result proves that similar sticky ends can mismatch when T4 ligase exists. This result enlighten us on improving TALE construction parts.</p>
+
<p>So the sequencing result proves that similar sticky ends can mismatch when T4 ligase exists. This result enlightens us on improving TALE construction parts.</p>
<p>2012 Freiburg's parts have seven sticky ends:</p>
<p>2012 Freiburg's parts have seven sticky ends:</p>
<p><center>TGAC,GCTC,CTTG,GCTT,ACTG,CCTG,ACTC</center></p>
<p><center>TGAC,GCTC,CTTG,GCTT,ACTG,CCTG,ACTC</center></p>
-
<p>Spired by BLAST algorithm, we calculate the similarity of each other sticky ends. </p>
+
<p>Inpired by BLAST algorithm, we calculated the similarity of each other sticky ends. </p>
<center><img src="https://static.igem.org/mediawiki/2014/8/8e/TAL%E7%B2%98%E6%80%A7%E6%9C%AB%E7%AB%AF%E8%A1%A8%E6%A0%BC.png" width=400px></img></center>
<center><img src="https://static.igem.org/mediawiki/2014/8/8e/TAL%E7%B2%98%E6%80%A7%E6%9C%AB%E7%AB%AF%E8%A1%A8%E6%A0%BC.png" width=400px></img></center>
<center><strong><small>Figure 2.1.6 Strict rules score table</small></strong></center>
<center><strong><small>Figure 2.1.6 Strict rules score table</small></strong></center>
Line 100: Line 100:
The table shows that more than 30% of pairs’ score is equal to 3, which means that the possibility of mismatch cannot be neglected.
The table shows that more than 30% of pairs’ score is equal to 3, which means that the possibility of mismatch cannot be neglected.
-
Even if we employ the relatively loose rule to calculate the similarity, we can still find that error rates cannot be neglected.</p>
+
Even if we employed the relatively loose rule to calculate the similarity, we still found that error rates cannot be neglected.</p>
<center><img src="https://static.igem.org/mediawiki/2014/9/9b/Tal_%E8%A1%A8%E6%A0%BC%E7%B2%98%E6%80%A7%E6%9C%AB%E7%AB%AF2.png" width=400px></img></center>
<center><img src="https://static.igem.org/mediawiki/2014/9/9b/Tal_%E8%A1%A8%E6%A0%BC%E7%B2%98%E6%80%A7%E6%9C%AB%E7%AB%AF2.png" width=400px></img></center>
Line 106: Line 106:
<p>So how to solve this problem?</p>
<p>So how to solve this problem?</p>
-
<p>Our team design seven new sticky ends which is theoretically better than original vision. See more information please go to <a href="https://2014.igem.org/Team:SJTU-BioX-Shanghai/Part3_TAL_Improvement" >TAL Improvement </a>page!</p>
+
<p>Our team designed seven new sticky ends which are theoretically better than original version. For more information please go to <a href="https://2014.igem.org/Team:SJTU-BioX-Shanghai/Part3_TAL_Improvement" >TAL Improvement </a>page!</p>
   </article>
   </article>

Revision as of 23:05, 17 October 2014

Wet Lab Results

Reformed Plasmid Result

We designed four reformed plasmids, pBluescript II KS(+) ScaI deletion, pBluescript II KS(+) EcoRV deletion, pBluescript II KS(+)_3_copy, pBluescript II KS(+)_5_copy. And we tested their co-transformation ability and got the result picture. All of these plasmids have Amp antibiotic resistance.

We co-transformed pRSFDuet-1 and two plasmids, pBluescript II KS(+) ScaI deletion & pBluescript II KS(+) EcoRV deletion, respectively. So the plate has two antibiotic resistance, Kan and Amp. We cultured two different strains on the plate and got the result picture.

Figure 2.1.1 Two plates of Co-transfected bacteria (pBluescript II KS(+) ScaI deletion & pBluescript II KS(+) EcoRV deletion)

Moreover, we verified our pBluescript II KS(+)_3_copy, pBluescript II KS(+)_5_copy part through lacl & blue-white spot screening.

Figure 2.1.2 Two plates of lacl & blue-white spot screening

So we have experimentally validated that our reformed plasmids perform as expected.

TAL USB function identification

The membrane anchor system (ssDsbA-Lgt) comes from iGEM12_SJTU-BioX-Shanghai BBa_K771000. In order to connect TAL protein designed by 2012 Freiburg iGEM team, the TAL USB also consists of T1 sequence, T14 sequence and two sites for type II restriction enzyme BsmBI.

Figure 2.1.3 The structure of TAL USB

When digested with BsmBI, this part produces two sticky-ends that can bind TAL-Protein (BBa_K747000 to BBa_K747095) After doing ligation with T4 ligase, we experimentally validated this part's function.

Sequencing result is followed:

GGAATTCCATATGAAAAAGATTTGGCTGGCGCTGGCTGGTTTAGTTTTAGCGTTTAGCGCATCGGCGATGGCTTCC TCCGAAGACGTTATCAAAGAGTTCATGCGTTTCAAAGTTCGTATGGAAGGTTCCGTTAACGGTCACGAGTTCGAAA TCGAAGGTGAAGGTGAAGGTCGTCCGTACGAAGGTACCCAGACCGCTAAACTGAAAGTTACCAAAGGTGGTCCGCT GCCGTTCGCTTGGGACATCCTGTCCCCGCAGTTCCAGTACGGTTCCAAAGCTTACGTTAAACACCCGGCTGACATC CCGGACTACCTGAAACTGTCCTTCCCGGAAGGTTTCAAATGGGAACGTGTTATGAACTTCGAAGACGGTGGTGTTG TTACCGTTACCCAGGACTCCTCCCTGCAAGACGGTGAGTTCATCTACAAAGTTAAACTGCGTGGTACCAACTTCCC GTCCGACGGTCCGGTTATGCAGAAAAAAACCATGGGTTGGGAAGCTTCCACCGAACGTATGTACCCGGAAGACGGT GCTCTGAAAGGTGAAATCAAAATGCGTCTGAAACTGAAAGACGGTGGTCACTACGACGCTGAAGTTAAAACCACCT ACATGGCTAAAAAACCGGTTCAGCTGCCGGGTGCTTACAAAACCGACATCAAACTGGACATCACCTCCCACAACGA AGACTACACCATCGTTGAACAGTACGAACGTGCTGAAGGTCGTCACTCCACCGGTGCTGCTGAGGCCGCCGCAAAA GAAGCAGCAGCTAAGGAAGCTGCGGCGAAGATGACCAGTAGCTATCTGCATTTTCCGGAGTTTGATCCGGTCATTT TCTCAATAGGACCCGTGGCGCTTCACTGGTACGGCCTGATGTATCTGGTGGGTTTCATTTTTGCAATGTGGCTGGC AACACGACGGGCGAATCGTCCGGGCAGCGGCTGGACCAAAAATGAAGTTGAAAACTTACTCTATGCGGGCTTCCTC GGCGTCTTCCTCGGGGGACGTATTGGTTATGTTCTGTTCTACAATTTCCCGCAGTTTATGGCCGATCCGCTGTATC TGTTCCGTGTCTGGGACGGCGGCATGTCTTTCCACGGCGGCCTGATTGGCGTTATCGTGGTGATGATTATCTTCGC CCGCCGTACTAAACGTTCCTTCTTCCAGGTCTCTGATTTTATCGCACCACTCATTCCGTTTGGTCTTGGTGCCGGG CGTCTGGGCAACTTTATTAACGGTGAATTGTGGGGCCGCGTTGACCCGAACTTCCCGTTTGCCATGCTGTTCCCTG GCTCCCGTACAGAAGATATTTTGCTGCTGCAAACCAACCCGCAGTGGCAATCCATTTTCGACACTTACGGTGTGCT GCCGCGCCACCCATCACAGCTTTACGAGCTGCTGCTGGAAGGTGTGGTGCTGTTTATTATCCTCAACCTGTATATT CGTAAACCACGCCCAATGGGAGCTGTCTCAGGTTTGTTCCTGATTGGTTACGGCGCGTTTCGCATCATTGTTGAGT TTTTCCGCCAGCCCGACGCGCAGTTTACCGGTGCCTGGGTGCAGTACATCAGCATGGGGCAAATTCTTTCCATCCC GATGATTGTCGCGGGTGTGATCATGATGGTCTGGGCATATCGTCGCAGCCCACAGCAACACGTTTCCTTAGGAGGT GGAGGTAGTGGTGGAGGTGGAAGTGGTGGAGGTGGTAGTGCTGCAGCTCTGGACACGGGCCAGTTGCTGAAGATCG CGAAGCGGGGAGGAGTCACGGCGGTCGAGGCGGTGCACGCGTGGCGCAATGCGCTCACGGGAGCACCCCTCAACCT GACCCCGGAACAGGTGGTGGCCATTGCAAGCAACGGTGGTGGCAAGCAGGCCCTGGAGACAGTCCAACGGCTGCTT CCGGTTCTGTGTCAGGCCCACGGCCTGACTCCAGAACAAGTGGTTGCTATCGCCAGCCACGATGGCGGTAAACAAG CCCTCGAAACCGTGCAGCGCCTGCTTCCGGTGCTGTGTCAGGCCCACGGGCTCACGCCTGAGCAGGTAGTGGCTAT TGCATCCAACGGAGGGGGCAGACCCGCACTGGAGTCAATCGTGGCCCAGCTTTCGAGGCCGGACCCCGCGCTGGCC CACCACCACCACCACCACTAACTCGAGCGG

Furthermore, we found some mismatch cases in our sequencing result. Here are a typical mismatch result.

There is the partial sequencing result.

Figure 2.1.4 Partial sequencing result of mismatch

We tried to understand why we got this wrong sequence. We checked our part and 2012 Freiburg's project. And we found that the the mismatch sticky ends appearing in original sequence are GCTC and ACTC. What similar sticky ends! Here are the two components in the mismatch sequence.

Figure 2.1.5 The process of generating mismatch

So the sequencing result proves that similar sticky ends can mismatch when T4 ligase exists. This result enlightens us on improving TALE construction parts.

2012 Freiburg's parts have seven sticky ends:

TGAC,GCTC,CTTG,GCTT,ACTG,CCTG,ACTC

Inpired by BLAST algorithm, we calculated the similarity of each other sticky ends.

Figure 2.1.6 Strict rules score table

The higher score, the higher similarity, and the higher possibility of mismatch. The table shows that more than 30% of pairs’ score is equal to 3, which means that the possibility of mismatch cannot be neglected. Even if we employed the relatively loose rule to calculate the similarity, we still found that error rates cannot be neglected.

Figure 2.1.7 Loose rules score table

So how to solve this problem?

Our team designed seven new sticky ends which are theoretically better than original version. For more information please go to TAL Improvement page!